189 results
Page 6 of 10
6-K
EX-99.1
0cspqd6c 4olr0y
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm
6-K
EX-99.2
usadpke
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
f7g8j h39lsdzvaob8f
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
skrpmlx 3i
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.1
vc4s31pbg9ehf
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.5
qxxuwmm
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
3kynk6bv
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
3q1d9 d9x6j
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.2
ixxbj
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.3
r567itt
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
7mfre
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
1l2gaun
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
oc8ir9 ni91sub
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
lj8bw7yuqkt0kra9dwg
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
fbggu oyz
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
8i0cb4x razn8
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
3d01p9s00fq9d
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
gfhm491ycy0
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
74bfbchgn7qww1ehffjb
26 Mar 19
Current report (foreign)
1:45pm